P

Inventor

TISSOT KATHRIN

DE11 patents
⚠️ This page may combine multiple inventors who share the name “TISSOT KATHRIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ESBATECH ALCON BIOMED RES UNIT

3 patents
US10125186B2Nov 13, 2018

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

ESBATECH ALCON BIOMED RES UNIT0 citations51
US10570190B2Feb 25, 2020

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

ESBATECH ALCON BIOMED RES UNIT0 citations50
US9518108B2Dec 13, 2016

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

ESBATECH ALCON BIOMED RES UNIT0 citations50

UNIV ZUERICH

2 patents
US9828420B2Nov 28, 2017

Method of providing disease-specific binding molecules and targets

UNIV ZUERICH14 citations91
US10202445B2Feb 12, 2019

Method of providing disease-specific binding molecules and targets

UNIV ZUERICH7 citations83

NOVARTIS AG

2 patents
US11357864B2Jun 14, 2022

Antibody drug conjugates for ablating hematopoietic stem cells

NOVARTIS AG0 citations59
US12171839B2Dec 24, 2024

Antibody drug conjugates for ablating hematopoietic stem cells

NOVARTIS AG1 citations58

NITSCH ROGER

1 patent
US8906367B2Dec 9, 2014

Method of providing disease-specific binding molecules and targets

NITSCH ROGER29 citations90

UNIV OF ZUERICH

1 patent
US10131708B2Nov 20, 2018

Methods of treating Alzheimer's disease

UNIV OF ZUERICH12 citations88

UNIV OF ZÜRICH

1 patent
US9670272B2Jun 6, 2017

Method of providing disease-specific binding molecules and targets

UNIV OF ZÜRICH14 citations88

TISSOT KATHRIN

1 patent
US8853362B2Oct 7, 2014

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

TISSOT KATHRIN12 citations79